Asian Spine Journal

Korean Society of Spine Surgery (대한척추외과학회)
권호 표지
DOI QR코드

DOI QR Code

Functional Recovery Following the Transplantation of Olfactory Ensheathing Cells in Rat Spinal Cord Injury Model

  • Muniswami, Durai Murugan (Department of Physical Medicine and Rehabilitation, Christian Medical College) ;
  • Tharion, George (Department of Physical Medicine and Rehabilitation, Christian Medical College)
  • Received : 2018.02.03
  • Accepted : 2018.04.17
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Study Design: Olfactory ensheathing cells (OECs) from rat olfactory mucosa were cultured, characterized, and transplanted into a rat model of spinal cord injury (SCI). Purpose: To evaluate different doses of OECs in a rat model of SCI. Overview of Literature: SCI causes permanent functional deficit because the central nervous system lacks the ability to perform spontaneous repair. Cell therapy strategies are being explored globally. The clinical use of human embryonic stem cell is hampered by ethical controversies. Alternatively, OECs are a promising cell source for neurotransplantation. This study aimed to evaluate the efficacy of different doses of allogenic OEC transplantation in a rat model of SCI. Methods: OECs were cultured from the olfactory mucosa of Albino Wistar rats; these cells were characterized using immunohistochemistry and flow cytometry. Rats were divided into five groups (n=6 rats each). In each group, different dosage ($2{\times}10^5$, $5{\times}10^5$, $10{\times}10^5$, and >$10{\times}10^5$) of cultured cells were transplanted into experimentally injured spinal cords of rat models. However, in the SCI group, only DMEM (Dulbecco's modified Eagle's medium) was injected. Rats were followed up upto 8 weeks post-transplantation. The outcome of transplantation was assessed using the Basso, Beattie, Bresnahan (BBB) scale; motor-evoked potential studies; and histological examination. Results: Cultured cells expressed 41% of p75NTR, a marker for OEC, and 35% of anti-fibronectin, a marker for olfactory nerve fibroblast. These cells also expressed $S100{\beta}$ and glial fibrillary acid protein of approximately 75% and 83%, respectively. All the transplanted groups showed promising BBB scores for hind-limb motor recovery compared with the SCI group (p<0.05). A motor-evoked potential study showed increased amplitude in all the treated groups compared with the SCI. Green fluorescent protein-labeled cells survived in the injured cord, suggesting their role in the transplantation-mediated repair. Transplantation of $5{\times}10^5$ cells showed the best motor outcomes among all the doses. Conclusions: OECs demonstrated a therapeutic effect in rat models with the potential for future clinical applications.

Keywords

References

  1. Kwon BK, Borisoff JF, Tetzlaff W. Molecular targets for therapeutic intervention after spinal cord injury. Mol Interv 2002;2:244-58. https://doi.org/10.1124/mi.2.4.244
  2. Lin XY, Lai BQ, Zeng X, et al. Cell transplantation and neuroengineering approach for spinal cord injury treatment: a summary of current laboratory findings and review of literature. Cell Transplant 2016;25:1425-38. https://doi.org/10.3727/096368916X690836
  3. Tso D, McKinnon RD. Cell replacement therapy for central nervous system diseases. Neural Regen Res 2015;10:1356-8. https://doi.org/10.4103/1673-5374.165209
  4. M ackay-Sim A. Neurogenesis in the adult olfactory neuroepithelium. In: Doty RL, editor. Handbook of olfaction and gustation. New York (NY): Dekker; 2003. p. 93-113.
  5. B arnett SC. Olfactory ensheathing cells: unique glial cell types? J Neurotrauma 2004;21:375-82. https://doi.org/10.1089/089771504323004520
  6. Li Y, Carlstedt T, Berthold CH, Raisman G. Interaction of transplanted olfactory-ensheathing cells and host astrocytic processes provides a bridge for axons to regenerate across the dorsal root entry zone. Exp Neurol 2004;188:300-8. https://doi.org/10.1016/j.expneurol.2004.04.021
  7. B oruch AV, Conners JJ, Pipitone M, et al. Neurotrophic and migratory properties of an olfactory ensheathing cell line. Glia 2001;33:225-9. https://doi.org/10.1002/1098-1136(200103)33:3<225::AID-GLIA1021>3.0.CO;2-Y
  8. Woodhall E, West AK, Chuah MI. Cultured olfactory ensheathing cells express nerve growth factor, brainderived neurotrophic factor, glia cell line-derived neurotrophic factor and their receptors. Brain Res Mol Brain Res 2001;88:203-13. https://doi.org/10.1016/S0169-328X(01)00044-4
  9. Imaizumi T, Lankford KL, Waxman SG, Greer CA, Kocsis JD. Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J Neurosci 1998;18:6176-85. https://doi.org/10.1523/JNEUROSCI.18-16-06176.1998
  10. Li Y, Decherchi P, Raisman G. Transplantation of olfactory ensheathing cells into spinal cord lesions restores breathing and climbing. J Neurosci 2003;23:727-31. https://doi.org/10.1523/JNEUROSCI.23-03-00727.2003
  11. B arbour HR, Plant CD, Harvey AR, Plant GW. Tissue sparing, behavioral recovery, supraspinal axonal sparing/regeneration following sub-acute glial transplantation in a model of spinal cord contusion. BMC Neurosci 2013;14:106. https://doi.org/10.1186/1471-2202-14-106
  12. Roet KC, Verhaagen J. Understanding the neural repair-promoting properties of olfactory ensheathing cells. Exp Neurol 2014;261:594-609. https://doi.org/10.1016/j.expneurol.2014.05.007
  13. Toft A, Scott DT, Barnett SC, Riddell JS. Electrophysiological evidence that olfactory cell transplants improve function after spinal cord injury. Brain 2007;130(Pt 4):970-84.
  14. Ziegler MD, Hsu D, Takeoka A, et al. Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp Neurol 2011;229:109-19. https://doi.org/10.1016/j.expneurol.2011.01.007
  15. B asso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12:1-21. https://doi.org/10.1089/neu.1995.12.1
  16. Prabhav NR, Devasahayam SR. Effect of muscle length changes on classification of EMG for prosthesis control. Int J Biomed Eng Technol 2013;13:117-32. https://doi.org/10.1504/IJBET.2013.057929
  17. Takami T, Oudega M, Bates ML, Wood PM, Kleitman N, Bunge MB . Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord. J Neurosci 2002;22:6670-81. https://doi.org/10.1523/JNEUROSCI.22-15-06670.2002
  18. B arnett SC, Chang L. Olfactory ensheathing cells and CNS repair: going solo or in need of a friend? Trends Neurosci 2004;27:54-60. https://doi.org/10.1016/j.tins.2003.10.011
  19. Lakatos A, Barnett SC, Franklin RJ. Olfactory ensheathing cells induce less host astrocyte response and chondroitin sulphate proteoglycan expression than Schwann cells following transplantation into adult CNS white matter. Exp Neurol 2003;184:237-46. https://doi.org/10.1016/S0014-4886(03)00270-X
  20. Wewetzer K, Verdu E, Angelov DN, Navarro X. Olfactory ensheathing glia and Schwann cells: two of a kind? Cell Tissue Res 2002;309:337-45. https://doi.org/10.1007/s00441-002-0607-y
  21. Jani HR, Raisman G. Ensheathing cell cultures from the olfactory bulb and mucosa. Glia 2004;47:130-7. https://doi.org/10.1002/glia.20038
  22. Raisman G. Olfactory ensheathing cells and repair of brain and spinal cord injuries. Cloning Stem Cells 2004;6:364-8. https://doi.org/10.1089/clo.2004.6.364
  23. B arnett SC, Alexander CL, Iwashita Y, et al. Identification of a human olfactory ensheathing cell that can effect transplant-mediated remyelination of demyelinated CNS axons. Brain 2000;123(Pt 8):1581-8. https://doi.org/10.1093/brain/123.8.1581
  24. Kato T, Honmou O, Uede T, Hashi K, Kocsis JD. Transplantation of human olfactory ensheathing cells elicits remyelination of demyelinated rat spinal cord. Glia 2000;30:209-18. https://doi.org/10.1002/(SICI)1098-1136(200005)30:3<209::AID-GLIA1>3.0.CO;2-8
  25. Richter MW, Fletcher PA, Liu J, Tetzlaff W, Roskams AJ. Lamina propria and olfactory bulb ensheathing cells exhibit differential integration and migration and promote differential axon sprouting in the lesioned spinal cord. J Neurosci 2005;25:10700-11. https://doi.org/10.1523/JNEUROSCI.3632-05.2005
  26. Okano H. Stem cell biology of the central nervous system. J Neurosci Res 2002;69:698-707. https://doi.org/10.1002/jnr.10343
  27. Torres-Espin A, Hernandez J, Navarro X. Gene expression changes in the injured spinal cord following transplantation of mesenchymal stem cells or olfactory ensheathing cells. PLoS One 2013;8:e76141. https://doi.org/10.1371/journal.pone.0076141
  28. Ziegler MD, Hsu D, Takeoka A, et al. Further evidence of olfactory ensheathing glia facilitating axonal regeneration after a complete spinal cord transection. Exp Neurol 2011;229:109-19. https://doi.org/10.1016/j.expneurol.2011.01.007
  29. Lu P, Yang H, Culbertson M, Graham L, Roskams AJ, Tuszynski MH. Olfactory ensheathing cells do not exhibit unique migratory or axonal growth-promoting properties after spinal cord injury. J Neurosci 2006;26:11120-30. https://doi.org/10.1523/JNEUROSCI.3264-06.2006
  30. Liu KJ, Xu J, Yang CY, et al. Analysis of olfactory ensheathing glia transplantation-induced repair of spinal cord injury by electrophysiological, behavioral, and histochemical methods in rats. J Mol Neurosci 2010;41:25-9. https://doi.org/10.1007/s12031-009-9223-6

Cited by

  1. Efficiency of Human Olfactory Ensheathing Cell Transplantation into Spinal Cysts to Improve Mobility of the Hind Limbs vol.28, pp.18, 2019, https://doi.org/10.1089/scd.2019.0092
  2. Optimizing Olfactory Ensheathing Cell Transplantation for Spinal Cord Injury Repair vol.37, pp.5, 2018, https://doi.org/10.1089/neu.2019.6939
  3. Elucidating the Pivotal Neuroimmunomodulation of Stem Cells in Spinal Cord Injury Repair vol.2021, pp.None, 2018, https://doi.org/10.1155/2021/9230866
  4. Considering the Cellular Composition of Olfactory Ensheathing Cell Transplants for Spinal Cord Injury Repair: A Review of the Literature vol.15, pp.None, 2018, https://doi.org/10.3389/fncel.2021.781489
  5. HUCMSCs transplantation combined with ultrashort wave therapy attenuates neuroinflammation in spinal cord injury through NUR77/ NF-κB pathway vol.267, pp.None, 2021, https://doi.org/10.1016/j.lfs.2020.118958